Evidence map›Paper›PMID 26734689›Full record

ArticleThe Analyst2016

Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry.

Jennifer E Kyle, Xing Zhang, Karl K Weitz, Matthew E Monroe, Yehia M Ibrahim, Ronald J Moore, Jeeyeon Cha, Xiaofei Sun, Erica S Lovelace, Jessica Wagoner and 6 more

Abstract read
In one paragraph

Article in The Analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 244 citations in OpenAlex.

  1. Article
  2. Aziridination-Enabled Structural and Quantitative Lipidomics.Journal of the American Society for Mass Spectrometry · 2026
    Review
  3. Review
  4. Direct Comparison of MRM-MS and PRM-MS Methods for Quantitative Ganglioside Analysis.Journal of the American Society for Mass Spectrometry · 2026
    Article
  5. New Analytical Technologies to Resolve, Interpret, and Understand Lipid Complexity.Annual review of analytical chemistry (Palo Alto, Calif.) · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Analytical chemistry · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Jennifer E KyleBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Xing ZhangBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Karl K WeitzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Matthew E MonroeBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Yehia M IbrahimBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Jeeyeon ChaCincinnati Children's Hospital, Cincinnati, OH, USA.
Xiaofei SunCincinnati Children's Hospital, Cincinnati, OH, USA.
Erica S LovelaceDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Jessica WagonerDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Stephen J PolyakDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA and Department of Global Health, University of Washington, Seattle, WA, USA.
Thomas O MetzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Sudhansu K DeyCincinnati Children's Hospital, Cincinnati, OH, USA.
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Kristin E Burnum-JohnsonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Erin S BakerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. erin.baker@pnnl.gov kristin.burnum-johnson@pnnl.gov.
Richland College · USCincinnati Children's Hospital Medical Center · USUniversity of Washington · US

Funding

Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KAWAOKA, YOSHIHIRO · 2013 to 2017
$26.1M
Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Molecular signaling in uterine receptivity to implantationR01HD068524 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI Xiaofei Sun · 2011 to 2026
$5.3M
Endocannabinoid Signaling During Early PregnancyR37DA006668 · NIDA · VANDERBILT UNIVERSITY · PI DEY, SUDHANSU K · 2003 to 2012
$3.8M
Mechanisms of Silymarin HepatoprotectionR01AT006842 · NCCIH · UNIVERSITY OF WASHINGTON · PI POLYAK, STEPHEN J. · 2011 to 2015
$2.7M
Platform Providing Increased Throughput, Sensitivity and Specificity for MetaboloR01ES022190 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI BAKER, ERIN S · 2012 to 2016
$2.2M
MARIJUANA EFFECTS ON EARLY PREGNANCYR01DA006668 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DEY, SUDHANSU K · 1990 to 2019
$2.1M
NCCIH NIH HHS 3R01AT006842-03S1NCCIH NIH HHS 5R01AT006842NCCIH NIH HHS R01 AT006842NIAID NIH HHS U19 AI106772NIAID NIH HHS U19AI106772NICHD NIH HHS HD068524NICHD NIH HHS R01 HD068524NIDA NIH HHS DA006668NIDA NIH HHS R01 DA006668NIDA NIH HHS R37 DA006668NIEHS NIH HHS R01 ES022190NIEHS NIH HHS R01ES022190NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Understanding how biological molecules are generated, metabolized and eliminated in living systems is important for interpreting processes such as immune response and disease pathology. While genomic and proteomic studies have provided vast amounts of information over the last several decades, interest in lipidomics has also grown due to improved analytical technologies revealing altered lipid metabolism in type 2 diabetes, cancer, and lipid storage disease. Mass spectrometry (MS) measurements are currently the dominant approach for characterizing the lipidome by providing detailed information on the spatial and temporal composition of lipids. However, interpreting lipids' biological roles is challenging due to the existence of numerous structural and stereoisomers (i.e. distinct acyl chain and double-bond positions), which are often unresolvable using present approaches. Here we show that combining liquid chromatography (LC) and structurally-based ion mobility spectrometry (IMS) measurement with MS analyses distinguishes lipid isomers and allows insight into biological and disease processes.

Indexed as

Chromatography, LiquidFatty AcidsLipidsMass SpectrometryMetabolomicsStereoisomerismFatty AcidsLipids

Identifiers

PMID26734689
PMCPMC4764491
OpenAlexW2223347777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.